Page last updated: 2024-09-05

phosphorodiamidic acid and 6-cyano-7-nitroquinoxaline-2,3-dione

phosphorodiamidic acid has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(phosphorodiamidic acid)
Trials
(phosphorodiamidic acid)
Recent Studies (post-2010)
(phosphorodiamidic acid)
Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)
Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)
Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
260102,6981353

Protein Interaction Comparison

ProteinTaxonomyphosphorodiamidic acid (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ai, J; Baker, A1

Other Studies

1 other study(ies) available for phosphorodiamidic acid and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Long-term potentiation of evoked presynaptic response at CA3-CA1 synapses by transient oxygen-glucose deprivation in rat brain slices.
    Experimental brain research, 2006, Volume: 169, Issue:1

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Glucose; Hippocampus; Hypoxia; In Vitro Techniques; Long-Term Potentiation; Phosphorus Compounds; Rats; Rats, Sprague-Dawley; Synapses; Tetrodotoxin; Time Factors

2006